azathioprine has been researched along with allopurinol in 137 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (25.55) | 18.7374 |
1990's | 15 (10.95) | 18.2507 |
2000's | 21 (15.33) | 29.6817 |
2010's | 55 (40.15) | 24.3611 |
2020's | 11 (8.03) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Flury, W; Montandon, A; Ruch, HR | 1 |
Hruby, K; Kopsa, H; Pils, P; Schmidt, P; Zazgornik, J | 1 |
Carpenter, CB; Hager, ET; Merrill, JP; Mocelin, AJ | 1 |
Glogner, P; Hopf, U; Stockhausen, G | 1 |
Bugge, C; Krasny, HC; Nelson, DJ | 1 |
Glogner, P; Heni, N | 1 |
Kaiser, E; Müller, MM | 1 |
Boyd, IW | 1 |
Lee, HA; Sharman, VL; Venkat Raman, G | 1 |
Nordstrom, D | 1 |
Erdmann, E; Greif, J | 1 |
Griggs, RC; Kissel, JT; Levy, RJ; Mendell, JR | 1 |
O'Sullivan, WJ | 1 |
Fellner, R; Fellner, S; Klein, G | 1 |
Marshall, VC | 1 |
Bertino, JR; Prager, D; Rosman, M | 1 |
Rothermich, NO | 1 |
Greene, ML; Henderson, JF; Kelley, WN; Rosenbloom, FM; Seegmiller, JE | 1 |
Ginn, HE | 1 |
Wilmanns, W | 1 |
Hitchings, GH | 1 |
Nies, AS; Oates, JA | 1 |
Crummy, CS; Moquin, RB; Perlin, E | 1 |
Datko, LJ; Kassarich, J; Rosenthale, ME; Schneider, F | 1 |
Kurumada, T; Maruyama, H; Mizuno, T; Onisawa, J; Segawa, M | 1 |
Atkinson, MR; Chalmers, AH; Knight, PR | 1 |
Benke, PJ; Sorensen, LB | 1 |
Didlake, R; Files, JC; Kirchner, KA; Krueger, RP; Raju, S | 1 |
Brown, CB; Fox, M; Lennard, L; Maddocks, JL | 1 |
Ahlmén, J; Brynger, J | 1 |
Breuer, RI; Kehoe, TJ; Krowka, MJ | 1 |
Brooks, RJ; Dorr, RT; Durie, BG | 1 |
Epifanova, OI; Loginov, BV; Makarova, GF | 1 |
Hoffman, R; Toledo-Pereyra, LH | 1 |
Hausamen, TU; Reinicke, H; Weber, FW | 1 |
Kokot, F | 1 |
Deutsch, E; Kopsa, H; Kuschan, K; Pils, P; Schmidt, P; Zazgornik, J | 1 |
Bahloul, Z; Ben Hmida, M; Hachicha, J; Jarraya, A; Jarraya, F; Kaddour, N; Kharrat, M | 1 |
Arap, S; Cameron, JS; Chocair, PR; Duley, JA; Ianhez, L; Sabbaga, E; Simmonds, HA | 1 |
Amirou, M; Bayle, F; Bechtel, Y; Bessard, G; Boujet, C; Serre-Debeauvais, F; Vialtel, P | 1 |
Arap, S; Cameron, JS; Chocair, P; Duley, J; Ianhez, L; Sabbaga, E; Simmonds, HA | 1 |
Bernstein, LS | 1 |
Banner, N; Cummins, D; Halil, O; Sekar, M | 1 |
Armstrong, VW; Gummert, J; Mohr, FW; Oellerich, M; Schütz, E | 1 |
Allen, LV; Erickson, MA | 1 |
Hayney, MS; Kennedy, DT; Lake, KD | 1 |
Aziz, T; Campbell, C; Deiraniya, A; el-Gamel, A; Evans, C; Keevil, B; Rahman, A; Yonan, N | 1 |
Alonso-Ruiz, A; Calabozo, M; Duruelo, J; Perez-Ruiz, F | 1 |
Chrzanowska, M; Krzymański, M | 1 |
Bechtel, PR; Bechtel, YC; Brientini, MP; Hrusovsky, S; Lelouët, H; Mantion, G; Miguet, JP; Paintaud, G | 1 |
Jenkins, PG | 1 |
Amenabar, JJ; Calabozo, M; Gomez-Ullate, P; Herrero-Beites, AM; Nolla, JM; Perez-Ruiz, F; Zarraga, S | 1 |
Farrell, GC; Jones, BE; Tapner, MJ; Wu, WM | 1 |
Seidel, W | 1 |
Cao, D; Friedman, S; Hanauer, SB; Hande, SA; Lim, WC; Reddy, SI; Sparrow, MP | 1 |
Duley, JA; Florin, TH | 1 |
Chocair, PR; Duley, JA; Florin, TH | 1 |
Derijks, LJ; Gilissen, LP; Hommes, DW; Hooymans, PM | 1 |
Edwards, NL | 1 |
Egan, LJ | 1 |
Cao, D; Friedman, S; Hanauer, SB; Hande, SA; Sparrow, MP | 1 |
den Dulk, MO; Derijks, LJ; Gemmeke, EH; Hooymans, PM; Wong, DR | 1 |
Ansari, A; Aslam, Z; De Sica, A; Duley, J; Fairbanks, L; Gilshenan, K; Marinaki, A; Sanderson, J; Smith, M | 1 |
Gearry, RB; Leong, RW; Sparrow, MP | 1 |
Feller, ER; Lam, MY; Lonks, JR; Shah, SA | 1 |
Ansari, A; Arenas, M; Duley, J; Lewis, CM; Marinaki, AM; Sanderson, JD; Shobowale-Bakre, M; Smith, MA | 1 |
Ansari, A; Duley, JA; Florin, TH; O'Donohue, J; Patel, N; Sanderson, J | 1 |
Barclay, ML; Day, AS; Gearry, RB; Leong, RW; Sparrow, MP | 1 |
Goetschel, P; Laube, GF; Trück, J; von Vigier, RO | 1 |
Sparrow, MP | 1 |
Barclay, ML; Gearry, RB; Roberts, RL | 1 |
Govani, SM; Higgins, PD | 1 |
Barclay, ML; Burt, MJ; Chalmers-Watson, T; Chapman, BA; Gardiner, SJ; Gearry, RB; Huelsen, A; Ross, AG; Stedman, CA | 1 |
Andersson, P; Hindorf, U | 1 |
Bouma, G; de Boer, NK; Peters, GJ; Seinen, ML; Smid, K; van Asseldonk, DP; van Bodegraven, AA | 1 |
Anderson, SH; Blaker, P; Irving, PM; Marinaki, AM; Sanderson, JD; Smith, MA | 1 |
Bouma, G; de Boer, NK; Hanauer, SB; Harrell, LE; Hoentjen, F; Rubin, DT; Seinen, ML; van Bodegraven, AA | 1 |
Appell, ML; Hindorf, U; Wagner, A | 1 |
Aomori, T; Araki, T; Hiromura, K; Nagamine, A; Nakamura, T; Nojima, Y; Okada, Y; Takenaka, M; Yamamoto, K | 1 |
Al-Shamma, S; Eross, B; Mclaughlin, S | 1 |
Ampuero, J; Castro-Fernández, M; Millán, M; Romero-Gómez, M | 1 |
Bouma, G; de Boer, NK; Losekoot, N; Mulder, CJ; Peters, GJ; Seinen, ML; Smid, K; van Asseldonk, DP; van Bodegraven, AA | 1 |
Bouma, G; de Boer, NK; de Boer, YS; Mulder, CJ; van Gerven, NM; van Nieuwkerk, CM | 1 |
Burke, PA; Gakhal, M; Malebranche, L; Rahman, E; Saltzberg, M | 1 |
Curkovic, I; Frei, P; Fried, M; Jetter, A; Kullak-Ublick, GA; Rentsch, KM; Rogler, G | 1 |
Arenas-Hernandez, M; Blaker, PA; Fairbanks, L; Irving, PM; Marinaki, AM; Sanderson, JD; Shobowale-Bakre, EA; Smith, MA | 1 |
Fukami, T; Higuchi, S; Matsuo, K; Nakajima, M; Sasaki, E; Takai, S; Tsuneyama, K; Yokoi, T | 1 |
Baek, MC; Cho, YE; Moon, PG | 1 |
McCabe, RP; Min, MX; Weinberg, DI | 1 |
Bégin, J; Doré, M; Frenette, AJ; Mansour, AM; Troyanov, Y | 1 |
Beswick, L; Friedman, AB; Sparrow, MP | 1 |
Aellig, N; Corti, N; Fauchère, I; Jetter, A; Weiler, S | 1 |
Al Maruf, A; O'Brien, PJ; Wan, L | 1 |
Kiszka-Kanowitz, M; Nielsen, AM; Theede, K | 2 |
Broekman, MM; de Jong, DJ; Hoentjen, F; Kerstholt, M; Leijten, A; Peters, WH; Roelofs, HM; Wanten, GJ; Wong, DR | 1 |
Ansari, A; Duley, J; Florin, T; Nelson-Piercy, C; Sheikh, M | 1 |
De Iudicibus, S; Decorti, G; Dei Rossi, S; Londero, M; Martelossi, S; Pelin, M; Spizzo, R; Stocco, G; Ventura, A | 1 |
de Boer, NK; Leijte, NN; Meijer, B; Mulder, CJ; Seinen, ML; van Bodegraven, AA | 1 |
Abdulrehman, A; Ansari, A; Bull, C; Duley, J; Kerr, P; Pavlidis, P; Stamoulos, P | 1 |
Kiszka-Kanowitz, M; Mertz-Nielsen, A; Theede, K | 1 |
Ansari, A; Berry, P; Coulthard, SA; McGarrity, S; McLaughlin, S; Redfern, CPF | 1 |
Bouma, G; de Boer, NKH; Meijer, B; Mulder, CJJ; Seinen, ML; van Bodegraven, AA; van Egmond, R | 1 |
Dart, RJ; Irving, PM | 1 |
Bruijnzeel-Koomen, CAF; De Bruin-Weller, MS; de Graaf, M; Garritsen, FM; Hijnen, DJ; van den Broek, MPH; van der Schaft, J | 1 |
Bampton, P; Barclay, ML; Brown, SJ; Chung, A; Friedman, AB; Gibson, PR; Hanauer, SB; Macrae, FA; McKenzie, J; Reynolds, J; Sparrow, MP | 1 |
Beswick, L; Friedman, AB; Haridy, J; Moltzen, A; Raghunath, A; Sparrow, M; van Langenberg, D; Vasudevan, A | 1 |
Boyle, B; Bricker, J; Crandall, W; Dotson, JL; Kim, SC; Maltz, R; Serpico, MR | 1 |
Friedman, AB; Sparrow, MP | 1 |
Ansari, AR; Aziz, A | 1 |
Krijt, J; Pavelcova, K; Petru, L; Stiburkova, B | 1 |
Bolia, R; Hardikar, W; Rajanayagam, J | 1 |
Allin, KH; Burisch, J; Gluud, LL; Hansen, S; Jensen, CB; Jess, T; Kiszka-Kanowitz, M; Nielsen, AM; Theede, K; Thomsen, SB | 1 |
Bouma, G; de Boer, NK; de Jong, DJ; de Veer, RC; de Vries, AC; Dijkstra, G; Kreijne, JE; van der Woude, CJ; van Moorsel, SAW; Voskuil, MD; West, R | 1 |
Czaja, AJ | 1 |
de Boer, A; Egberts, ACG; Houwen, JPA; Houwen, RHJ; Lalmohamed, A; van Maarseveen, EM | 1 |
Hsia, CC; Jones, E; Madrazo, L | 1 |
Bi, HC; Chen, BL; Ding, L; Gao, X; Hu, PJ; Huang, L; Huang, M; Liu, H; Lv, C; Wang, XD; Zhang, FB; Zhang, Y | 1 |
Anderson, SHC; Ansari, AR; Bayoumy, AB; de Boer, NKH; Hayee, B; Mateen, BA; Mulder, CJJ; Nolan, JD; van Liere, ELSA; Warner, B | 1 |
Abad-Santos, F; Campodónico, D; Casajús, A; Gómez, A; Mejía-Abril, G; Méndez, M; Navares-Gómez, M; Novalbos, J; Ochoa, D; Román, M; Soria-Chacartegui, P; Villapalos-García, G; Zubiaur, P | 1 |
Giri, S; Sundaram, S | 1 |
Sparrow, MP; Turbayne, AK | 1 |
Borrelli, O; Buckingham, R; Chadokufa, S; Cococcioni, L; El-Kouly, S; Gaynor, E; Kiparissi, F; Pensabene, L; Puoti, MG; Saliakellis, E | 1 |
18 review(s) available for azathioprine and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An updated look at antirheumatic drugs.
Topics: Allopurinol; Anti-Inflammatory Agents; Arthritis; Azathioprine; Chloroquine; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Indomethacin; Methotrexate; Nitrogen Mustard Compounds; Rheumatic Diseases; Salicylates | 1967 |
Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout.
Topics: Adenine; Adolescent; Adult; Allopurinol; Azathioprine; Child; Child, Preschool; Female; Gout; Humans; Hypoxanthines; Male; Middle Aged; Pedigree; Pharmacogenetics; Phenotype; Purines; Transferases; Uric Acid | 1969 |
Late medical complications of renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Allopurinol; Autoimmune Diseases; Azathioprine; Bone Diseases; Diabetes Mellitus; Drug Synergism; Duodenal Ulcer; Embolism, Fat; Glomerulonephritis; Histocompatibility; Humans; Hypertension, Renal; Immunosuppressive Agents; Infections; Kidney Glomerulus; Kidney Transplantation; Malabsorption Syndromes; Male; Mercaptopurine; Neoplasm Transplantation; Neoplasms; Obesity; Osteoporosis; Pancreatitis; Peptic Ulcer Hemorrhage; Phenylbutazone; Postoperative Complications; Proteinuria; Transplantation, Homologous | 1969 |
[Antimetabolites].
Topics: Allopurinol; Animals; Antimetabolites; Azathioprine; Cell Division; Chemical Phenomena; Chemistry; Cytarabine; DNA, Neoplasm; Fluorouracil; Folic Acid Antagonists; Humans; Leukemia; Mercaptopurine; Methotrexate; Neoplasms; Pyrimidines; Thioguanine | 1971 |
Chemotherapy and comparative biochemistry: G. H. A. Clowes memorial lecture.
Topics: Allopurinol; Animals; Antimetabolites; Azathioprine; Binding Sites; Drug Therapy; Enzyme Inhibitors; Enzyme Precursors; Folic Acid; Folic Acid Antagonists; Humans; Lactobacillus; Leukemia, Myeloid; Liver; Mercaptopurine; Methotrexate; Mice; Molecular Weight; Neoplasms; Nucleic Acids; Proteus; Purines; Research; Species Specificity; Thymine; Transferases; Uric Acid; Xanthine Oxidase | 1969 |
Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides.
Topics: Azathioprine; Drug Monitoring; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Leukopenia; Mercaptopurine; Methylation; Methyltransferases; Nausea; Thioguanine; Thionucleotides; Xanthine Oxidase | 2005 |
Review article: thiopurines in inflammatory bowel disease.
Topics: Azathioprine; Drug Interactions; Gastrointestinal Agents; Genotype; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methyltransferases; Phenotype; Purines; Thioguanine; Treatment Outcome; Xanthine Oxidase | 2006 |
Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.
Topics: Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Diseases; Mercaptopurine | 2008 |
Azathioprine and allopurinol: A two-edged interaction.
Topics: Allopurinol; Asian People; Azathioprine; Consumer Product Safety; Drug Interactions; Drug Labeling; Drug Monitoring; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methyltransferases; New South Wales; Polymorphism, Single Nucleotide; Risk Factors | 2010 |
Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.
Topics: Allopurinol; Azathioprine; Drug Monitoring; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Practice Guidelines as Topic | 2014 |
The role of thiopurine metabolite monitoring in inflammatory bowel disease.
Topics: Allopurinol; Antimetabolites; Azathioprine; Drug Monitoring; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methyltransferases | 2014 |
[Optimized thiopurine treatment in chronic inflammatory bowel disease].
Topics: Algorithms; Allopurinol; Antimetabolites; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methyltransferases | 2014 |
[Optimized thiopurine treatment in chronic inflammatory bowel disease].
Topics: Algorithms; Allopurinol; Antimetabolites; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methyltransferases | 2015 |
Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress.
Topics: Animals; Antimetabolites; Azathioprine; Biotransformation; Glutathione; Glutathione Transferase; Humans; Liver; Mercaptopurine; Metabolic Detoxication, Phase II; Oxidative Stress; Pharmacogenetics; Polymorphism, Single Nucleotide; Pyrophosphatases; Reactive Oxygen Species; Risk Factors; Xanthine Oxidase | 2016 |
Optimising use of thiopurines in inflammatory bowel disease.
Topics: Allopurinol; Drug Dosage Calculations; Drug Therapy, Combination; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Mercaptopurine; Practice Guidelines as Topic | 2017 |
Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis.
Topics: Allopurinol; Azathioprine; Drug-Related Side Effects and Adverse Reactions; Guanine Nucleotides; Hepatitis, Autoimmune; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Purines; Quality Improvement; Thioguanine; Thionucleotides; Treatment Outcome | 2020 |
Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo.
Topics: Allopurinol; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine | 2022 |
9 trial(s) available for azathioprine and allopurinol
Article | Year |
---|---|
[Indomethacin in rheumatic diseases with special reference to ophthalmologic studies].
Topics: Allopurinol; Arthritis, Rheumatoid; Azathioprine; Blood Cells; Capsules; Clinical Trials as Topic; Eye Diseases; Female; Gastrointestinal Diseases; Gout; Humans; Indomethacin; Lupus Erythematosus, Systemic; Male; Middle Aged; Rheumatic Diseases; Scleroderma, Systemic; Spondylitis, Ankylosing; Suppositories | 1972 |
Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
Topics: Adult; Allopurinol; Azathioprine; Case-Control Studies; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukocyte Count; Male; Prednisolone | 1994 |
Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen.
Topics: Allopurinol; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Prednisolone | 1993 |
Effect of allopurinol on the metabolism of azathioprine in heart transplant patients.
Topics: Allopurinol; Azathioprine; Erythrocytes; Graft Rejection; Guanine Nucleotides; Heart Transplantation; Humans; Immunosuppressive Agents; Regression Analysis; Thionucleotides | 1998 |
Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series.
Topics: Adolescent; Adult; Allopurinol; Azathioprine; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Hypoxanthine Phosphoribosyltransferase; Inflammatory Bowel Diseases; Male; Mercaptopurine; Middle Aged; Young Adult | 2011 |
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
Topics: Adolescent; Adult; Allopurinol; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Medication Adherence; Mercaptopurine; Middle Aged; Treatment Outcome; Young Adult | 2013 |
Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations.
Topics: Adult; Aged; Allopurinol; Azathioprine; Female; Guanine Nucleotides; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Middle Aged; Thionucleotides | 2013 |
Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease.
Topics: Adult; Aged; Allopurinol; Azathioprine; Denmark; Drug Therapy, Combination; Feces; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Inflammatory Bowel Diseases; Leukocyte L1 Antigen Complex; Male; Methyltransferases; Middle Aged; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2016 |
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
Topics: Adolescent; Adult; Allopurinol; Azathioprine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Middle Aged; Treatment Outcome; Young Adult | 2018 |
110 other study(ies) available for azathioprine and allopurinol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[The treatment of hyperuricemia after kidney transplantation].
Topics: Allopurinol; Azathioprine; Benzbromarone; Creatinine; Drug Interactions; Female; Humans; Kidney Transplantation; Male; Transplantation, Homologous; Uric Acid; Urinary Calculi | 1977 |
[Hemolysis after combined azathioprine and allopurinol therapy].
Topics: Adult; Allopurinol; Anemia, Hemolytic; Azathioprine; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Mercaptopurine; Transplantation, Homologous | 1979 |
[Medullar aplasia due to concomitant use of azathioprine and allopurinol in kidney transplantation. Probable beneficial effects of infusion of leukemic cells].
Topics: Adult; Allopurinol; Anemia, Aplastic; Azathioprine; Blood Transfusion; Drug Interactions; Humans; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Myeloid; Leukocytes; Male; Transplantation, Homologous | 1976 |
[Pancytopenia following a combination therapy with allopurinol and azathioprine. Discussion contribution and conclusion].
Topics: Allopurinol; Azathioprine; Drug Therapy, Combination; Humans; Male; Middle Aged; Pancytopenia | 1977 |
Oxypurine and 6-thiopurine nucleoside triphosphate formation in human erythrocytes.
Topics: Allopurinol; Azathioprine; Erythrocytes; Humans; Inosine Nucleotides; Mercaptopurine; Methionine; Methylation; Purine Nucleotides; Sulfhydryl Compounds; Thioinosine; Thionucleotides; Xanthines | 1977 |
[Pancytopenia following combination treatment with allopurinol and azathioprine].
Topics: Allopurinol; Anemia, Aplastic; Azathioprine; Drug Interactions; Drug Therapy, Combination; Gout; Humans; Male; Middle Aged | 1976 |
[Regulation of purine metabolism and its modification by drugs].
Topics: Allopurinol; Antimetabolites; Azathioprine; Benzofurans; Chemical Phenomena; Chemistry; Erythrocytes; Folic Acid Antagonists; Glutamine; Gout; Humans; Metabolic Clearance Rate; Methotrexate; Purines; Time Factors; Transferases; Xanthine Oxidase | 1975 |
Allopurinol-azathioprine interaction.
Topics: Aged; Allopurinol; Azathioprine; Drug Interactions; Hematologic Diseases; Humans; Male; Middle Aged | 1991 |
Cyclosporine-induced hyperuricemia and gout.
Topics: Allopurinol; Azathioprine; Cyclosporins; Drug Interactions; Gout; Humans; Transplantation, Homologous; Uric Acid | 1990 |
Azathioprine and allopurinol: a potentially dangerous combination.
Topics: Adolescent; Adult; Allopurinol; Azathioprine; Bone Marrow Diseases; Drug Interactions; Female; Humans; Kidney Transplantation; Leukocyte Count; Male; Middle Aged; Platelet Count | 1990 |
Rheumatoid arthritis refractory to standard therapy.
Topics: Allopurinol; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Humans; Liver | 1988 |
[Life-threatening interaction between azathioprine and allopurinol].
Topics: Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Hemolysis; Humans; Kidney Transplantation; Male; Middle Aged; Pancreatitis; Pancytopenia; Postoperative Complications; Uric Acid | 1985 |
Azathioprine toxicity in neuromuscular disease.
Topics: Allopurinol; Azathioprine; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukopenia; Liver; Male; Neuromuscular Diseases; Time Factors | 1986 |
Metabolic side-effects of allopurinol.
Topics: Allopurinol; Antipyrine; Azathioprine; Azauridine; Benzothiadiazines; Dicumarol; Diuretics; Drug Synergism; Erythrocytes; Humans; Leukocytes; Mercaptopurine; Orotic Acid; Pentosyltransferases; Pyrimidines; Sodium Chloride Symporter Inhibitors; Thymidine; Xanthine Oxidase | 1974 |
Skin tumours in immunosuppressed patients.
Topics: Adolescent; Adult; Allopurinol; Antineoplastic Agents; Azathioprine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Facial Neoplasms; Female; Hand; Humans; Immunosuppressive Agents; Keratoacanthoma; Keratosis; Kidney Transplantation; Leg; Lip Neoplasms; Male; Middle Aged; Nose Neoplasms; Postoperative Complications; Skin Neoplasms; Transplantation, Homologous | 1973 |
Letter: Azathioprine and allopurinol.
Topics: Allopurinol; Azathioprine; Drug Interactions; Humans | 1974 |
Clinicopathologic conference: hypertension and the lupus syndrome--revisited.
Topics: Allopurinol; Azathioprine; Blood Cell Count; Bone Marrow; Bone Marrow Diseases; Drug Interactions; Humans; Hypertension; Kidney Diseases; Male; Middle Aged | 1971 |
Microangiopathic hemolytic anemia in Wegener's granulomatosis.
Topics: Allopurinol; Anemia, Hemolytic; Azathioprine; Granulomatosis with Polyangiitis; Heparin; Humans; Male; Microcirculation; Middle Aged; Prednisone; Remission, Spontaneous; Thrombophlebitis | 1971 |
Chemotherapy of experimental allergic encephalomyelitis (EAE).
Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; Chloroquine; Colchicine; Cortisone; Cyclophosphamide; Cyproheptadine; Diazoxide; Dimethyl Sulfoxide; Encephalomyelitis, Autoimmune, Experimental; Hydrocortisone; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Methyldopa; Nialamide; Oils; Organ Size; Rats; Strychnine; Talc; Thalidomide; Thioguanine; Thiomalates | 1969 |
Clinical and therapeutic aspects of the Lesch-Nyhan syndrome in Japanese children.
Topics: Allopurinol; Athetosis; Azathioprine; Benzofurans; Child; Child, Preschool; Guanine; Humans; Hypoxanthines; Intellectual Disability; Japan; Ketones; Lesch-Nyhan Syndrome; Male; Paraplegia; Pentosyltransferases; Phenols; Purine-Pyrimidine Metabolism, Inborn Errors; Self Mutilation; Spasm; Uric Acid; Xanthines | 1970 |
6-thiopurines as substrates and inhibitors of purine oxidases: a pathway for conversion of azathioprine into 6-thiouric acid without release of 6-mercaptopurine.
Topics: Alkanes; Animals; Azathioprine; Cattle; Chemical Phenomena; Chemistry; Glutathione; Humans; Liver; Mercaptopurine; Milk; Oxidoreductases; Rabbits; Uric Acid; Xanthine Oxidase | 1969 |
Biochemical evidence for a distinct type of primary gout.
Topics: Adolescent; Allopurinol; Azathioprine; Carbon; Carbon Isotopes; Enzymes; Glycine; Gout; Humans; Hypoxanthines; Male; Purines; Uric Acid; Xanthine Oxidase; Xanthines | 1967 |
Chronic granulocytic leukemia after renal transplantation.
Topics: Adult; Allopurinol; Azathioprine; Humans; Hydroxyurea; Kidney Transplantation; Leukemia, Myeloid; Male; Melphalan; Postoperative Complications; Prednisone | 1983 |
Azathioprine metabolism in kidney transplant recipients.
Topics: Adult; Allopurinol; Azathioprine; Dose-Response Relationship, Drug; Female; Guanine Nucleotides; Humans; Individuality; Kidney Transplantation; Leukocyte Count; Leukopenia; Male; Sex Factors; Thionucleotides | 1984 |
[Drug interference complicates therapy of kidney transplantation patients].
Topics: Adult; Allopurinol; Azathioprine; Drug Interactions; Humans; Kidney Transplantation; Male | 1982 |
Azathioprine-associated pulmonary dysfunction.
Topics: Adult; Allopurinol; Azathioprine; Crohn Disease; Humans; Inflammation; Kidney Calculi; Lung Diseases; Male; Pulmonary Alveoli | 1983 |
Interaction of allopurinol with 6-mercaptopurine and azathioprine.
Topics: Aged; Allopurinol; Azathioprine; Blood Cell Count; Bone Marrow; Drug Interactions; Humans; Male; Mercaptopurine; Prednisone; Time Factors | 1982 |
[Causes of the preferential action of imuran on the viability and proliferative activity of a Chinese hamster cell culture in the stationary growth phase].
Topics: Allopurinol; Animals; Antimetabolites; Azathioprine; Cell Division; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Enzyme Activation; Mercaptopurine; Purines; Xanthine Oxidase | 1980 |
A study of the immunosuppressive effect of allopurinol.
Topics: Allopurinol; Animals; Azathioprine; Dogs; Dose-Response Relationship, Immunologic; Drug Synergism; Graft Survival; Immune Tolerance; Leukocyte Count; Lymphocytes; Male; Mice; Mice, Inbred A; Mice, Inbred DBA; Skin Transplantation | 1980 |
[Myelosuppression with macrocytic anaemia and leucopenia during treatment with azathioprine in myasthenia gravis].
Topics: Allopurinol; Anemia, Macrocytic; Azathioprine; Drug Interactions; Female; Humans; Leukopenia; Middle Aged; Myasthenia Gravis | 1982 |
[Use of immunosuppresive agents in the treatment of kidney diseases. Drug therapy of uremia and kidney calculi].
Topics: Allopurinol; Azathioprine; Benzothiadiazines; Cyclophosphamide; Diuretics; Glucocorticoids; Humans; Kidney Calculi; Kidney Diseases; Penicillamine; Phosphates; Sodium Chloride Symporter Inhibitors; Uremia | 1982 |
Increased danger of bone marrow damage in simultaneous azathioprine-allopurinol therapy.
Topics: Adult; Allopurinol; Azathioprine; Bone Marrow Diseases; Drug Therapy, Combination; Female; Humans | 1981 |
Cyclosporine-induced hyperuricemia and gout in renal transplants.
Topics: Adult; Allopurinol; Azathioprine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Humans; Immunosuppressive Agents; Kidney Transplantation; Uric Acid | 1995 |
[Hematotoxicity caused by azathioprine genetically determined and aggravated by xanthine oxidase deficiency in a patient following renal transplantation].
Topics: Azathioprine; Female; Humans; Immune Tolerance; Kidney Diseases; Kidney Transplantation; Leukopenia; Middle Aged; Postoperative Complications; Xanthine Oxidase | 1995 |
The interaction between allopurinol and azathioprine.
Topics: Allopurinol; Azathioprine; Drug Interactions; Humans | 1993 |
Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation.
Topics: Adult; Aged; Allopurinol; Azathioprine; Bone Marrow; Drug Interactions; Gout Suppressants; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Middle Aged; Retrospective Studies | 1996 |
Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation.
Topics: Azathioprine; Chromatography, High Pressure Liquid; DNA; Erythrocytes; Female; Guanine Nucleotides; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Radioimmunoassay; Thionucleotides; White People; Xanthine Oxidase | 1996 |
Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids.
Topics: Acetazolamide; Allopurinol; Azathioprine; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Clonazepam; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Flucytosine; Hydrogen-Ion Concentration; Solutions; Temperature | 1996 |
Azathioprine and allopurinol: the price of an avoidable drug interaction.
Topics: Allopurinol; Azathioprine; Cost of Illness; Drug Interactions; Gout Suppressants; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancytopenia; Quality of Life | 1996 |
Treatment of gout after transplantation.
Topics: Allopurinol; Azathioprine; Cyclosporine; Diuretics; Drug Interactions; Furosemide; Gout; Gout Suppressants; Heart Transplantation; Humans; Postoperative Complications; Uric Acid | 1998 |
Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine.
Topics: Adult; Allopurinol; Antimetabolites; Azathioprine; Erythrocytes; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mercaptopurine; Middle Aged; Thioguanine | 1999 |
Caffeine metabolism before and after liver transplantation.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Azathioprine; Caffeine; Case-Control Studies; Cyclosporine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Humans; Immunosuppressive Agents; Liver; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mixed Function Oxygenases; Reference Values; Uracil; Xanthine Oxidase | 2001 |
Uric acid or urate nephropathy?
Topics: Allopurinol; Azathioprine; Biopsy; Diagnosis, Differential; Drug Interactions; Humans; Kidney; Kidney Diseases; Mycophenolic Acid; Uric Acid | 2001 |
Long-term efficacy of hyperuricaemia treatment in renal transplant patients.
Topics: Adolescent; Adult; Aged; Allopurinol; Antimetabolites; Azathioprine; Child; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Time Factors | 2003 |
Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury.
Topics: Adenosine Triphosphate; Allopurinol; Animals; Antioxidants; Azathioprine; Cell Differentiation; Cell Survival; Cells, Cultured; Chromans; Enzyme Inhibitors; Glutathione; Glutathione Disulfide; Hepatocytes; Male; Mercaptopurine; Microscopy, Electron; Mitochondria, Liver; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Time Factors; Xanthine Oxidase | 2004 |
[Panzytopenia from combination therapy with azathioprin and allopurinol].
Topics: Aged; Allopurinol; Antirheumatic Agents; Autoantibodies; Azathioprine; Blood Cell Count; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Erythrocyte Count; Female; Gout Suppressants; Hematopoiesis; Humans; Hyperuricemia; Lupus Erythematosus, Systemic; Pancytopenia | 2004 |
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Topics: Allopurinol; Antimetabolites; Azathioprine; Drug Combinations; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Thioguanine | 2005 |
Observations on the use of allopurinol in combination with azathioprine or mercaptopurine.
Topics: Allopurinol; Antimetabolites; Azathioprine; Drug Combinations; Drug Synergism; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Thioguanine | 2005 |
Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Contraindications; Drug Interactions; Gout; Gout Suppressants; Humans; Hypertension; Hyperuricemia; Immunosuppressive Agents; Male; Middle Aged; Renal Insufficiency, Chronic | 2006 |
A nudge in the right direction: shaping the metabolic fate of thiopurines for therapeutic gain.
Topics: Allopurinol; Azathioprine; Drug Synergism; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine | 2007 |
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
Topics: Allopurinol; Azathioprine; Drug Synergism; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Thioguanine; Treatment Outcome | 2007 |
The role of xanthine oxidase in thiopurine metabolism: a case report.
Topics: Azathioprine; Female; Humans; Mercaptopurine; Middle Aged; Pancreatitis, Chronic; Xanthine Oxidase | 2007 |
Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease.
Topics: Adult; Biological Availability; Case-Control Studies; Crohn Disease; Female; Humans; Immunosuppressive Agents; Intestine, Small; Mercaptopurine; Methyltransferases; Uric Acid; Xanthine Oxidase | 2008 |
Inflammatory bowel disease potpourri: a vignette-based discussion.
Topics: Adult; Allopurinol; Azathioprine; Clostridioides difficile; Colitis, Ulcerative; Crohn Disease; Drug Interactions; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gout; Gout Suppressants; Histoplasmosis; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Psoas Abscess; Tumor Necrosis Factor-alpha | 2009 |
Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Oxidoreductases; Aldehyde Oxidase; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methyltransferases; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Statistics as Topic; Treatment Outcome; Xanthine Dehydrogenase; Xanthine Oxidase; Young Adult | 2009 |
Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Azathioprine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; London; Male; Mercaptopurine; Middle Aged; Queensland; Retrospective Studies; Treatment Outcome | 2010 |
Gout in pediatric renal transplant recipients.
Topics: Adolescent; Allopurinol; Arthritis, Gouty; Azathioprine; Biopsy; Child; Gout Suppressants; Humans; Immunosuppressive Agents; Kidney Transplantation; Magnetic Resonance Imaging; Male; Treatment Outcome | 2010 |
IBD: Switching metabolism-can two drugs be better than one?
Topics: Allopurinol; Antimetabolites; Azathioprine; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mercaptopurine | 2010 |
Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?
Topics: Allopurinol; Azathioprine; Biotransformation; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Polymorphism, Genetic; Xanthine Oxidase | 2010 |
Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD.
Topics: Adult; Allopurinol; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Middle Aged; Opportunistic Infections; Retrospective Studies; Young Adult | 2010 |
Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents; Azathioprine; Biotransformation; Drug Therapy, Combination; Enzyme Inhibitors; Erythrocyte Count; Female; Gastrointestinal Agents; Guanine Nucleotides; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Middle Aged; New Zealand; Red-Cell Aplasia, Pure; Retrospective Studies; Steroids; Thionucleotides; Time Factors; Treatment Outcome; Xanthine Oxidase | 2011 |
How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?
Topics: Allopurinol; Antibodies, Monoclonal; Antimetabolites; Azathioprine; Drug Therapy, Combination; Female; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methyltransferases; Mycophenolic Acid; Practice Patterns, Physicians'; Surveys and Questionnaires; Sweden; Tacrolimus; Thioguanine; Tumor Necrosis Factor-alpha | 2011 |
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methyltransferases; Middle Aged; Purine Nucleotides; Retrospective Studies; Statistics, Nonparametric; Thioguanine; Treatment Outcome; Young Adult | 2012 |
A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol.
Topics: Adult; Allopurinol; Azathioprine; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Resistance; Erythrocytes; Female; Free Radical Scavengers; Genotype; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methyltransferases; Middle Aged; Thioguanine | 2013 |
Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Asian People; Azathioprine; Female; Genotype; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lupus Erythematosus, Systemic; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Pyrophosphatases; Retrospective Studies; Severity of Illness Index; Xanthine Oxidase | 2012 |
Use of a xanthine oxidase inhibitor in autoimmune hepatitis.
Topics: Allopurinol; Azathioprine; Enzyme Inhibitors; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Middle Aged; Prednisolone; Treatment Outcome; Xanthine Oxidase | 2013 |
[Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease].
Topics: Aged; Allopurinol; Azathioprine; Biotransformation; Bone Marrow Diseases; Crohn Disease; Drug Interactions; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methyltransferases; Xanthine Oxidase | 2013 |
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
Topics: Adult; Allopurinol; Azathioprine; Drug Therapy, Combination; Enzyme Activation; Enzyme Inhibitors; Fatigue; Female; Guanine Nucleotides; Humans; Hypoxanthine Phosphoribosyltransferase; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methyltransferases; Middle Aged; Nausea; Prospective Studies; Thioinosine; Thionucleotides; Xanthine Oxidase | 2013 |
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis.
Topics: Adult; Aged; Alanine Transaminase; Allopurinol; Antimetabolites; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Male; Mercaptopurine; Methyltransferases; Middle Aged; Salvage Therapy; Thioguanine | 2013 |
Sustained improvement of cardiac function with immunosuppressive therapy in a case of acute lymphocytic myocarditis secondary to allopurinol induced Stevens-Johnson syndrome.
Topics: Adrenal Cortex Hormones; Aged; Allopurinol; Antimetabolites; Azathioprine; Drug Therapy, Combination; Female; Heart; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Myocarditis; Stevens-Johnson Syndrome | 2012 |
Mechanism of allopurinol induced TPMT inhibition.
Topics: Adult; Allopurinol; Azathioprine; Case-Control Studies; Drug Therapy, Combination; Erythrocytes; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methyltransferases; Oxypurinol; Prospective Studies; Xanthines | 2013 |
Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury.
Topics: Animals; Azathioprine; Carrier Proteins; Chemical and Drug Induced Liver Injury; Female; Glutathione; Immunity, Innate; Inflammation; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Tumor Necrosis Factor-alpha; Xanthine Oxidase | 2014 |
An integrated proteomic and transcriptomic approach to understanding azathioprine- induced hepatotoxicity in rat primary hepatocytes.
Topics: Animals; Azathioprine; Cell Survival; Gene Expression Profiling; Hepatocytes; Male; Mitogen-Activated Protein Kinase Kinases; Proteome; Proteomics; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation; Xanthine Oxidase | 2014 |
Febuxostat as a novel option to optimize thiopurines' metabolism in patients with inadequate metabolite levels.
Topics: Adult; Azathioprine; Drug Interactions; Enzyme Inhibitors; Febuxostat; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Mercaptopurine; Muscular Diseases; Thiazoles; Thionucleotides; Xanthine Oxidase | 2014 |
Treatment of gout in a renal transplant patient leading to severe thrombocytopenia.
Topics: Aged; Allopurinol; Azathioprine; Diagnosis, Differential; Female; Gout; Gout Suppressants; Humans; Immunosuppressive Agents; Kidney Transplantation; Severity of Illness Index; Thrombocytopenia | 2014 |
Evaluation of azathioprine-induced cytotoxicity in an in vitro rat hepatocyte system.
Topics: Allopurinol; Animals; Azathioprine; Glutathione; Graft Rejection; Hepatocytes; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Organ Transplantation; Oxidative Stress; Rats; Reactive Oxygen Species | 2014 |
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Cell Line, Tumor; Hepatocytes; Humans; Mercaptopurine; Mesalamine | 2015 |
Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease.
Topics: Adult; Allopurinol; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Treatment Outcome | 2015 |
Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease.
Topics: Adolescent; Adult; Allopurinol; Azathioprine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Retrospective Studies; Young Adult | 2016 |
Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Antimetabolites; Azathioprine; Blood Sedimentation; C-Reactive Protein; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunosuppressive Agents; Intestinal Mucosa; Male; Methyltransferases; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone.
Topics: Allopurinol; Azathioprine; Biomarkers; Deoxyguanosine; DNA; Drug Therapy, Combination; Gene Expression; Gene Expression Profiling; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukocyte Count; Methyltransferases; Pilot Projects; United Kingdom | 2017 |
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
Topics: Adult; Allopurinol; Azathioprine; Drug Monitoring; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Middle Aged; Retrospective Studies; Thioguanine; Treatment Outcome; Young Adult | 2017 |
Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.
Topics: Adult; Allopurinol; Azathioprine; Chronic Disease; Dermatitis, Atopic; Drug Therapy, Combination; Eczema; Female; Foot Dermatoses; Guanine Nucleotides; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Prospective Studies; Thionucleotides; Time Factors; Treatment Outcome | 2018 |
Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Allopurinol; Australia; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Fatigue; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Linear Models; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
Topics: Adolescent; Adult; Allopurinol; Azathioprine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease-authors' reply.
Topics: Allopurinol; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine | 2018 |
Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease.
Topics: Allopurinol; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine | 2018 |
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II).
Topics: Adult; Aldehyde Oxidase; Female; Humans; Mercaptopurine; Methyltransferases; Polymorphism, Genetic; Purine-Pyrimidine Metabolism, Inborn Errors; Sulfurtransferases; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthine Oxidase | 2018 |
Lower 6-MMP/6-TG Ratio May Be a Therapeutic Target in Pediatric Autoimmune Hepatitis.
Topics: Allopurinol; Antimetabolites; Azathioprine; Child; Female; Guanine Nucleotides; Hepatitis, Autoimmune; Humans; Liver Function Tests; Maintenance Chemotherapy; Male; Mercaptopurine; Retrospective Studies; Thionucleotides; Treatment Outcome | 2018 |
Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.
Topics: Adult; Allopurinol; Azathioprine; Colitis, Ulcerative; Crohn Disease; Denmark; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Remission Induction; Severity of Illness Index; Signal Transduction; Thioguanine; Treatment Outcome | 2020 |
Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients.
Topics: Adult; Allopurinol; Azathioprine; Clinical Laboratory Techniques; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Male; Mercaptopurine; Middle Aged; Netherlands; Predictive Value of Tests; Prognosis; Purines; Retrospective Studies; Young Adult | 2020 |
Influence of allopurinol on thiopurine associated toxicity: A retrospective population-based cohort study.
Topics: Adult; Allopurinol; Azathioprine; Cohort Studies; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Retrospective Studies; Treatment Outcome | 2021 |
Azathioprine-induced severe anemia potentiated by the concurrent use of allopurinol.
Topics: Allopurinol; Anemia, Aplastic; Azathioprine; Bile Duct Diseases; Erythrocyte Transfusion; Gout Suppressants; Humans; Immunosuppressive Agents; Male; Middle Aged | 2021 |
Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients.
Topics: Adolescent; Adult; Aged; Asian People; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mercaptopurine; Middle Aged; Retrospective Studies; Xanthine Oxidase; Young Adult | 2021 |
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases.
Topics: Allopurinol; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Retrospective Studies; Treatment Outcome | 2022 |
Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Topics: Allopurinol; Azathioprine; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Immunosuppressive Agents; Incidence; Methyltransferases; Prescriptions; Retrospective Studies | 2022 |
Low Dose Azathioprine with Allopurinol in IBD: Early Days to Call It a Recipe for Success.
Topics: Allopurinol; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine | 2022 |
Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease.
Topics: Allopurinol; Azathioprine; Child; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Retrospective Studies; Treatment Outcome | 2023 |